MENU
GDTC
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
CytoMed Therapeutics (GDTC) Ownership - Who owns CytoMed Therapeutics?
CytoMed Therapeutics Ltd is a pre-clinical biopharmaceutical company focused on harnessing its proprietary technologies to create novel cell-based immunotherapies for the treatment of human cancers... Show more
Profile
Industry
N/A
Address
1 Commonwealth Lane
Phone
+65 62507738
Employees
28
Web
https://w2.cytomed.sg
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
21.58M
P/E Ratio
N/A
Total Cash
N/A
Projected Growth
N/A
Total Debt
N/A
Revenue
N/A
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash/Share
N/A
Total Debt/Equity
N/A
Revenue/Share
0.00 USD as % of share price
Fundamentals
GDTC
Capitalization
21.6M
P/E Ratio
N/A
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash
N/A
Total Cash/Share
N/A
Total Debt
N/A
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.00%
Revenue
N/A
ROE
N/A
Book Value
N/A
P/B Ratio
3.09
Cash Flow
N/A
Earnings
N/A
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
N/A
Current Ratio
N/A
Current Revenue Per Employee
N/A
Dividends Per Share - Security
N/A
EBITDA
N/A
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
N/A
Shares Held By Institutions
10.3K
Shares Outstanding - Current
11.5M
Total Liabilities
N/A
Total Volume MTD
N/A
Value
-1
Gain YTD
-45.000
View a ticker or compare two or three
VS
VS
Show more...
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. GDTC showed earnings on May 05, 2025. You can read more about the earnings report here.
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
1 Commonwealth Lane
Phone
+65 62507738
Employees
28
Web
https://w2.cytomed.sg